marketcaparena
Search

    BLFS

    BIOLIFE SOLUTIONS INC

    Company overview

    Market capitalization
    $1.91B
    Employees
    155
    Latest publication
    2026-09-29
    About BIOLIFE SOLUTIONS INC

    BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20192019-12-31 · USDQ2 20192019-06-30 · USDQ1 20192019-03-31 · USDQ4 20182018-12-31 · USD
    Total Revenue28,466,000USD27,500,000USD18,785,000USD28,067,000USD8,296,000USD6,701,000USD5,770,000USD5,456,000USD
    Cost Of Revenue10,179,000USD10,089,000USD6,108,000USD10,845,000USD3,070,000USD1,958,000USD1,647,000USD1,710,000USD
    Gross Profit18,287,000USD17,411,000USD12,677,000USD17,222,000USD5,226,000USD4,743,000USD4,123,000USD3,746,000USD
    Research Development2,958,000USD2,650,000USD66,000USD2,709,000USD748,000USD739,000USD372,000USD315,000USD
    Selling And Marketing Expenses2,782,000USD2,526,000USD—2,528,000USD1,666,000USD928,000USD848,000USD637,000USD
    General And Administrative Expenses10,694,000USD———————
    Other Operating Expenses157,000USD———————
    Total Operating Expenses16,591,000USD17,384,000USD6,857,000USD17,311,000USD5,807,000USD3,785,000USD3,424,000USD2,703,000USD
    Operating Income1,696,000USD27,000USD5,820,000USD-89,000USD-581,000USD919,000USD491,000USD1,043,000USD
    Total Other Income Expense Net1,057,000USD1,221,000USD-2,458,000USD792,000USD-13,287,000USD-81,000USD-64,000USD-149,940USD
    Income Before Tax2,753,000USD1,248,000USD3,362,000USD703,000USD-13,779,000USD838,000USD427,000USD893,000USD
    Income Tax Expense-42,351,000USD62,000USD-173,000USD82,000USD-1,541,000USD39,000USD208,000USD149,940USD
    Discontinued Operations0USD——————0USD
    Net Income45,104,000USD1,186,000USD3,535,000USD621,000USD-12,238,000USD838,000USD427,000USD893,000USD
    Selling General Administrative—12,208,000USD10,548,000USD12,074,000USD2,314,000USD2,118,000USD2,204,000USD1,751,000USD
    Interest Income—1,041,000USD——89,000USD137,000USD64,000USD—
    Net Interest Income—1,041,000USD833,000USD508,000USD89,000USD136,000USD168,000USD—
    Tax Provision—62,000USD-173,000USD82,000USD-1,541,000USD———
    Net Income From Continuing Ops—1,186,000USD3,535,000USD621,000USD-12,238,000USD838,000USD427,000USD892,571USD
    Ebit—27,000USD3,514,000USD-89,000USD-581,000USD4,253,000USD430,000USD894,454USD
    Ebitda—726,000USD4,898,000USD1,246,000USD378,000USD4,468,000USD528,000USD987,527USD
    Depreciation And Amortization—699,000USD1,384,000USD1,335,000USD959,000USD215,000USD98,000USD93,073USD
    Reconciled Depreciation—699,000USD586,000USD1,335,000USD959,000USD215,000USD98,000USD93,073USD
    Unclassified Operating Expenses——-3,757,000USD—1,079,000USD———
    Interest Expense——152,000USD508,000USD0USD1,000USD3,000USD1,455USD
    Non Operating Income Net Other————-12,746,000USD-80,000USD-61,000USD-148,485USD
    Net Income Applicable To Common Shares————-12,238,000USD838,000USD427,000USD832,754USD
    Minority Interest———————0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20182018-12-31 · USDFY 20132013-12-31 · USDFY 20122012-12-31 · USDFY 20082008-12-31 · USDFY 20052005-12-31 · USDFY 20042004-12-31 · USDFY 20032003-12-31 · USDFY 20022002-12-31 · USD
    Total Revenue19,742,000USD8,949,401USD5,662,990USD1,322,497USD614,718USD626,709USD605,511USD848,791USD
    Cost Of Revenue6,217,000USD5,186,514USD3,370,571USD770,646USD250,078USD163,979USD2,157,000USD1,429,000USD
    Gross Profit13,525,000USD3,762,887USD2,292,419USD551,851USD364,640USD462,730USD605,511USD848,791USD
    Research Development1,298,000USD487,816USD463,638USD457,640USD27,855USD29,087USD759,309USD644,798USD
    Selling General Administrative5,950,000USD2,718,977USD2,151,817USD2,185,341USD964,318USD1,092,067USD1,443,330USD824,104USD
    Selling And Marketing Expenses2,615,000USD841,451USD619,202USD372,324USD————
    Total Operating Expenses9,863,000USD4,048,244USD3,234,657USD3,015,305USD992,173USD1,121,154USD2,202,639USD1,468,902USD
    Operating Income3,662,000USD-285,357USD-942,238USD-2,463,454USD-627,533USD-658,424USD-1,597,128USD-620,111USD
    Interest Income281,000USD———————
    Interest Expense5,000USD742,219USD733,430USD284,762USD1,943USD84,738USD52,314USD506,381USD
    Net Interest Income276,000USD———————
    Income Before Tax3,266,000USD-1,084,160USD-1,659,586USD-2,496,709USD-619,323USD-743,162USD-1,303,368USD-638,026USD
    Income Tax Expense396,000USD798,803USD-368USD60,156USD-13,308USD79,338USD-563,946USD-329,606USD
    Net Income3,266,000USD-1,084,160USD-1,659,586USD-2,775,117USD-619,323USD-743,162USD-1,303,368USD215,876USD
    Net Income From Continuing Ops3,266,000USD-1,084,160USD-1,659,586USD—————
    Ebit3,662,000USD-285,357USD-942,238USD-2,446,600USD-627,533USD-658,424USD-1,391,475USD-620,111USD
    Ebitda4,000,000USD-38,285USD-772,594USD-2,417,319USD-561,445USD-492,220USD-1,139,887USD-451,231USD
    Depreciation And Amortization338,000USD247,072USD169,644USD29,281USD66,088USD166,204USD251,588USD168,880USD
    Reconciled Depreciation338,000USD———————
    Total Other Income Expense Net-396,000USD-798,803USD-717,348USD-311,663USD8,210USD-84,738USD88,107USD-17,915USD
    Non Operating Income Net Other-391,000USD-56,584USD16,082USD—————
    Net Income Applicable To Common Shares2,927,000USD-1,084,160USD-1,659,586USD—————
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets447,494,000USD400,906,000USD405,884,000USD392,081,000USD387,240,000USD395,141,000USD399,487,000USD381,652,000USD
    Cash And Equivalents23,997,000USD———————
    Total Current Assets135,198,000USD133,222,000USD136,561,000USD126,566,000USD125,432,000USD131,129,000USD148,761,000USD89,383,000USD
    Other Current Assets6,539,000USD6,335,000USD9,526,000USD8,945,000USD5,916,000USD5,816,000USD5,996,000USD5,098,000USD
    Other Non Current Assets3,289,000USD———————
    Total Liabilities27,491,000USD———————
    Total Current Liabilities13,947,000USD18,253,000USD22,979,000USD27,146,000USD28,312,000USD27,723,000USD32,734,000USD32,166,000USD
    Other Non Current Liabilities399,000USD———————
    Total Stockholder Equity420,003,000USD372,230,000USD371,888,000USD353,739,000USD347,155,000USD352,624,000USD348,909,000USD325,461,000USD
    Total Equity Including Noncontrolling Interest420,003,000USD———————
    Short Long Term Debt0USD2,499,000USD4,997,000USD7,492,000USD10,051,000USD10,449,000USD10,943,000USD12,231,000USD
    Net Receivables10,652,000USD13,057,000USD7,953,000USD10,842,000USD10,060,000USD9,167,000USD9,168,000USD17,918,000USD
    Inventory35,591,000USD32,834,000USD30,155,000USD27,825,000USD27,690,000USD27,566,000USD29,013,000USD32,179,000USD
    Property Plant Equipment Net23,879,000USD21,617,000USD22,179,000USD18,734,000USD17,199,000USD16,733,000USD16,758,000USD32,141,000USD
    Goodwill208,587,000USD———————
    Intangible Assets3,654,000USD3,932,000USD4,257,000USD7,450,000USD8,149,000USD8,857,000USD9,559,000USD18,415,000USD
    Accounts Payable2,482,000USD3,750,000USD1,486,000USD2,890,000USD3,209,000USD3,297,000USD3,573,000USD3,838,000USD
    Short Term Debt2,593,000USD4,815,000USD7,240,000USD9,670,000USD12,217,000USD12,284,000USD12,454,000USD15,342,000USD
    Common Stock49,000USD49,000USD48,000USD48,000USD48,000USD48,000USD47,000USD46,000USD
    Retained Earnings-293,406,000USD-338,510,000USD-339,696,000USD-350,766,000USD-351,387,000USD-335,549,000USD-335,101,000USD-347,560,000USD
    Accumulated Other Comprehensive Income-211,000USD-120,000USD132,000USD130,000USD71,000USD33,000USD24,000USD-208,000USD
    Total Liab—28,676,000USD33,996,000USD38,342,000USD40,085,000USD42,517,000USD50,578,000USD56,191,000USD
    Other Current Liab—7,369,000USD14,058,000USD10,751,000USD9,149,000USD8,096,000USD12,348,000USD11,499,000USD
    Capital Stock—49,000USD48,000USD48,000USD48,000USD48,000USD47,000USD46,000USD
    Good Will—208,587,000USD208,587,000USD212,304,000USD212,304,000USD212,304,000USD212,304,000USD224,741,000USD
    Cash—22,822,000USD33,038,000USD29,481,000USD31,902,000USD66,945,000USD95,386,000USD23,977,000USD
    Cash And Short Term Investments—80,996,000USD88,927,000USD78,954,000USD81,766,000USD88,580,000USD104,584,000USD34,188,000USD
    Current Deferred Revenue—206,000USD195,000USD154,000USD162,000USD117,000USD103,000USD435,000USD
    Net Debt—-7,965,000USD-15,141,000USD-8,804,000USD-8,087,000USD-39,997,000USD-65,212,000USD15,290,000USD
    Short Long Term Debt Total—14,857,000USD17,897,000USD20,677,000USD23,815,000USD26,948,000USD30,174,000USD39,267,000USD
    Long Term Investments—30,499,000USD31,250,000USD19,444,000USD18,471,000USD20,050,000USD5,623,000USD5,879,000USD
    Short Term Investments—58,174,000USD55,889,000USD49,473,000USD49,864,000USD21,635,000USD9,198,000USD10,211,000USD
    Property Plant Equipment Gross—26,975,000USD27,113,000USD23,681,000USD21,920,000USD21,231,000USD21,058,000USD42,372,000USD
    Common Stock Shares Outstanding—49,248,075shares48,645,084shares48,723,535shares47,798,146shares47,134,720shares48,032,700shares46,175,345shares
    Non Current Assets Total—267,684,000USD269,323,000USD265,515,000USD261,808,000USD264,012,000USD250,726,000USD292,269,000USD
    Non Current Liabilities Total—10,423,000USD11,017,000USD11,196,000USD11,773,000USD14,794,000USD17,844,000USD24,025,000USD
    Non Current Liabilities Other—183,000USD171,000USD—————
    Non Currrent Assets Other—3,049,000USD3,050,000USD7,583,000USD5,685,000USD6,068,000USD6,482,000USD12,088,000USD
    Net Working Capital—114,969,000USD113,582,000USD99,420,000USD97,120,000USD103,406,000USD116,027,000USD57,217,000USD
    Unclassified Non Current Liabilities—10,240,000USD10,846,000USD11,196,000USD11,773,000USD12,295,000USD12,847,000USD16,202,000USD
    Unclassified Equity—710,762,000USD711,356,000USD704,279,000USD698,375,000USD688,044,000USD683,892,000USD673,137,000USD
    Unclassified Current Liabilities——-4,997,000USD-3,811,000USD-6,476,000USD-6,520,000USD-6,687,000USD-11,179,000USD
    Long Term Debt—————2,499,000USD4,997,000USD7,823,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets405,884,000USD399,487,000USD412,714,000USD450,229,000USD552,604,000USD234,829,000USD93,011,000USD45,467,000USD
    Intangible Assets4,257,000USD9,559,000USD21,149,000USD32,088,000USD152,149,000USD31,049,000USD21,982,000USD—
    Other Current Assets9,526,000USD5,996,000USD14,307,000USD6,910,000USD4,427,000USD4,648,000USD1,263,000USD353,000USD
    Total Liab33,996,000USD50,578,000USD75,051,000USD86,041,000USD76,239,000USD29,583,000USD9,985,000USD2,319,000USD
    Total Stockholder Equity371,888,000USD348,909,000USD337,663,000USD364,188,000USD480,751,000USD205,246,000USD83,026,000USD43,148,000USD
    Other Current Liab14,058,000USD12,348,000USD21,002,000USD18,709,000USD23,145,000USD9,129,000USD3,515,000USD1,219,000USD
    Common Stock48,000USD47,000USD45,000USD43,000USD42,000USD33,000USD21,000USD19,000USD
    Capital Stock48,000USD47,000USD45,000USD43,000USD42,000USD33,000USD21,000USD19,000USD
    Retained Earnings-339,696,000USD-335,101,000USD-313,342,000USD-246,915,000USD-105,020,000USD-97,385,000USD-100,052,000USD-71,031,000USD
    Good Will208,587,000USD212,304,000USD224,741,000USD224,741,000USD224,741,000USD58,449,000USD33,637,000USD—
    Cash33,038,000USD95,386,000USD27,896,000USD19,442,000USD69,870,000USD90,456,000USD6,448,000USD30,657,000USD
    Cash And Short Term Investments88,927,000USD104,584,000USD44,184,000USD62,702,000USD69,870,000USD90,456,000USD6,448,000USD30,657,000USD
    Total Current Assets136,561,000USD148,761,000USD120,604,000USD138,452,000USD125,859,000USD114,712,000USD24,177,000USD37,564,000USD
    Total Current Liabilities22,979,000USD32,734,000USD42,178,000USD44,582,000USD42,700,000USD15,573,000USD7,775,000USD1,939,000USD
    Current Deferred Revenue195,000USD103,000USD661,000USD548,000USD814,000USD931,000USD324,000USD130,000USD
    Net Debt-15,141,000USD-65,212,000USD5,931,000USD24,271,000USD-42,991,000USD-79,303,000USD-5,094,000USD-30,657,000USD
    Short Term Debt7,240,000USD12,454,000USD7,571,000USD4,832,000USD3,769,000USD1,729,000USD817,000USD—
    Short Long Term Debt4,997,000USD10,943,000USD6,833,000USD1,814,000USD862,000USD614,000USD——
    Short Long Term Debt Total17,897,000USD30,174,000USD33,827,000USD43,713,000USD26,879,000USD11,153,000USD1,354,000USD—
    Long Term Investments31,250,000USD5,623,000USD5,617,000USD6,401,000USD4,372,000USD5,872,000USD2,500,000USD6,548,000USD
    Short Term Investments55,889,000USD9,198,000USD16,288,000USD43,260,000USD0USD5,872,000USD——
    Net Receivables7,953,000USD9,168,000USD18,657,000USD33,936,000USD23,217,000USD8,006,000USD5,345,000USD3,045,000USD
    Inventory30,155,000USD29,013,000USD43,456,000USD34,904,000USD28,345,000USD11,602,000USD11,121,000USD3,509,000USD
    Accounts Payable1,486,000USD3,573,000USD6,940,000USD15,367,000USD14,945,000USD3,672,000USD3,119,000USD720,000USD
    Property Plant Equipment Net22,179,000USD16,758,000USD32,617,000USD39,202,000USD36,802,000USD19,812,000USD6,612,000USD1,319,000USD
    Property Plant Equipment Gross27,113,000USD21,058,000USD42,119,000USD48,373,000USD43,543,000USD19,795,000USD6,612,000USD1,319,000USD
    Accumulated Other Comprehensive Income132,000USD24,000USD-345,000USD-679,000USD-282,000USD0USD0USD-2,328,000USD
    Common Stock Shares Outstanding48,645,084shares46,067,073shares43,719,185shares42,481,027shares38,503,944shares27,306,258shares19,460,299shares16,256,465shares
    Non Current Assets Total269,323,000USD250,726,000USD292,110,000USD311,777,000USD426,745,000USD120,117,000USD68,834,000USD7,903,000USD
    Non Current Liabilities Total11,017,000USD17,844,000USD32,873,000USD41,459,000USD33,539,000USD14,010,000USD2,210,000USD380,000USD
    Non Current Liabilities Other171,000USD——2,328,000USD4,942,000USD4,515,000USD2,087,000USD31,000USD
    Non Currrent Assets Other3,050,000USD6,482,000USD-20,876,000USD9,345,000USD9,809,000USD4,705,000USD3,922,000USD36,000USD
    Net Working Capital113,582,000USD116,027,000USD78,426,000USD93,870,000USD85,889,000USD99,139,000USD16,444,000USD35,625,000USD
    Unclassified Current Liabilities-4,997,000USD-6,687,000USD—3,312,000USD————
    Unclassified Non Current Liabilities10,846,000USD12,847,000USD14,562,000USD12,760,000USD-9,639,000USD-5,170,000USD-80,620,000USD-28,896,000USD
    Unclassified Equity711,356,000USD683,892,000USD651,260,000USD611,696,000USD585,969,000USD302,565,000USD183,036,000USD116,469,000USD
    Long Term Debt—4,997,000USD18,311,000USD23,793,000USD6,353,000USD655,000USD——
    Unclassified Non Current Assets——7,986,000USD-386,164,000USD-427,873,000USD-119,887,000USD——
    Other Liab———2,578,000USD31,883,000USD14,010,000USD41,141,000USD28,896,000USD
    Other Assets———386,164,000USD426,745,000USD120,117,000USD50,000USD36,000USD
    Net Tangible Assets———364,188,000USD480,751,000USD205,246,000USD-12,165,000USD43,148,000USD
    Unclassified Current Assets—————-5,872,000USD——
    Deferred Long Term Liab——————39,602,000USD349,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income1,186,000USD621,000USD-15,838,000USD-448,000USD12,459,000USD-15,276,000USD-20,719,000USD-10,221,000USD
    Depreciation699,000USD1,335,000USD1,382,000USD1,384,000USD1,704,000USD2,317,000USD2,362,000USD2,278,000USD
    Stock Based Compensation4,806,000USD5,904,000USD5,859,000USD4,153,000USD10,692,000USD5,329,000USD8,719,000USD6,183,000USD
    Other Non Cash Items-310,000USD1,219,000USD15,835,000USD394,000USD-24,357,000USD13,119,000USD12,864,000USD-81,000USD
    Change To Account Receivables-5,104,000USD-782,000USD-893,000USD1,000USD-1,233,000USD208,000USD-1,939,000USD65,000USD
    Change To Inventory-2,679,000USD-197,000USD-187,000USD1,447,000USD-1,343,000USD317,000USD1,765,000USD42,000USD
    Change In Working Capital-6,881,000USD-2,989,000USD85,000USD-3,762,000USD1,123,000USD-594,000USD3,233,000USD-2,639,000USD
    Total Cash From Operating Activities-491,000USD6,104,000USD7,368,000USD1,727,000USD1,645,000USD4,802,000USD6,459,000USD-4,475,000USD
    Capital Expenditures-167,000USD-3,302,000USD-1,743,000USD-175,000USD-1,062,000USD-1,114,000USD-995,000USD-356,000USD
    Free Cash Flow-658,000USD2,802,000USD5,625,000USD1,552,000USD583,000USD3,688,000USD5,464,000USD-4,831,000USD
    Investments-1,663,000USD-5,967,000USD-39,533,000USD-27,176,000USD73,637,000USD-1,681,000USD-13,435,000USD-221,000USD
    Total Cashflows From Investing Activities-1,830,000USD-5,967,000USD-39,533,000USD-27,176,000USD73,637,000USD-1,681,000USD-13,435,000USD-221,000USD
    Net Borrowings-2,500,000USD-2,500,000USD-2,500,000USD-2,500,000USD-3,426,000USD-2,714,000USD——
    Total Cash From Financing Activities-7,895,000USD-2,558,000USD-2,878,000USD-2,992,000USD-4,086,000USD-1,041,000USD-704,000USD-952,000USD
    Change In Cash-10,216,000USD-2,421,000USD-35,042,999USD-28,441,000USD71,225,000USD2,116,000USD-7,680,000USD-5,713,000USD
    Begin Period Cash Flow33,038,000USD31,902,000USD66,945,000USD95,386,000USD24,161,000USD22,045,000USD29,725,000USD35,438,000USD
    End Period Cash Flow22,822,000USD29,481,000USD31,902,000USD66,945,000USD95,386,000USD24,161,000USD22,045,000USD29,725,000USD
    Other Cashflows From Investing Activities122,000USD-373,000USD-10,078,000USD-250,000USD-300,000USD-13,066,000USD-1,130,000USD-973,000USD
    Other Cashflows From Financing Activities-5,585,000USD-58,000USD-396,000USD-492,000USD-725,000USD1,627,000USD-568,000USD-711,000USD
    Unclassified Investing Cash Flow—3,675,000USD11,821,000USD—1,362,000USD14,180,000USD2,125,000USD1,329,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-4,595,000USD-20,184,000USD-66,427,000USD-139,805,000USD-7,635,000USD2,667,000USD-1,657,000USD3,266,000USD
    Depreciation4,687,000USD5,491,000USD12,295,000USD16,472,000USD12,865,000USD5,068,000USD1,797,000USD338,000USD
    Stock Based Compensation22,993,000USD30,923,000USD31,670,000USD25,334,000USD13,956,000USD5,981,000USD3,043,000USD1,519,000USD
    Other Non Cash Items5,874,000USD-7,962,000USD8,559,000USD109,653,000USD-1,637,000USD-2,123,000USD4,043,000USD-127,000USD
    Change To Account Receivables264,000USD-2,899,000USD15,351,000USD-10,753,000USD-10,132,000USD-1,786,000USD-290,000USD-2,024,000USD
    Change To Inventory-1,268,000USD781,000USD-8,552,000USD-6,559,000USD114,000USD-629,000USD-3,777,000USD-1,662,000USD
    Change In Working Capital-8,909,000USD227,000USD1,467,000USD-14,905,000USD-2,258,000USD-1,781,000USD-4,472,000USD-3,320,000USD
    Total Cash From Operating Activities20,115,000USD8,431,000USD-12,498,000USD-8,489,000USD-4,836,000USD6,515,000USD1,213,000USD2,348,000USD
    Capital Expenditures-19,699,000USD-3,227,000USD-6,381,000USD-10,385,000USD-8,385,000USD-4,633,000USD-675,000USD-500,000USD
    Free Cash Flow416,000USD5,204,000USD-18,879,000USD-18,874,000USD-13,221,000USD1,882,000USD538,000USD1,848,000USD
    Investments-74,470,000USD58,300,000USD-1,014,000USD-58,117,000USD-12,642,000USD-23,731,000USD1,000,000USD-6,000,000USD
    Total Cashflows From Investing Activities-71,539,000USD58,300,000USD17,837,000USD-58,117,000USD-12,642,000USD-23,731,000USD-27,018,000USD-6,500,000USD
    Net Borrowings-10,000,000USD-6,608,000USD-498,000USD17,836,000USD-2,894,000USD984,000USD984,000USD-56,000USD
    Total Cash From Financing Activities-10,924,000USD-6,783,000USD10,591,000USD16,317,000USD-2,778,000USD102,078,000USD1,596,000USD28,146,000USD
    Issuance Of Capital Stock0USD0USD10,244,000USD0USD-130,000USD100,121,000USD—20,000,000USD
    Change In Cash-62,348,000USD59,948,000USD15,965,000USD-50,397,000USD-20,586,000USD84,008,000USD-24,209,000USD23,994,000USD
    Begin Period Cash Flow95,386,000USD35,438,000USD19,473,000USD69,870,000USD90,456,000USD6,448,000USD30,657,000USD6,663,000USD
    End Period Cash Flow33,038,000USD95,386,000USD35,438,000USD19,473,000USD69,870,000USD90,456,000USD6,448,000USD30,657,000USD
    Other Cashflows From Investing Activities-11,107,000USD-2,367,999USD-4,856,000USD-3,536,000USD-5,816,000USD-3,175,000USD-1,655,000USD-6,000,000USD
    Other Cashflows From Financing Activities-942,000USD-377,000USD845,000USD-1,711,000USD-1,157,000USD973,000USD1,596,000USD8,582,000USD
    Unclassified Investing Cash Flow33,737,000USD5,594,999USD30,088,000USD13,921,000USD14,201,000USD7,808,000USD-25,688,000USD6,000,000USD
    Change To Liabilities———0USD2,018,000USD-171,000USD441,000USD486,000USD
    Unclassified Operating Cash Flow———-5,238,000USD-20,127,000USD-3,297,000USD-1,541,000USD—
    Unclassified Financing Cash Flow————1,403,000USD-1,511,000USD-2,739,000USD24,306,000USD
    Sale Purchase Of Stock—————101,632,000USD1,755,000USD-4,250,000USD
    Cash And Cash Equivalents Changes—————84,008,000USD-24,209,000USD23,994,000USD
    Dividends Paid——————0USD-436,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2022Quarterly · 2022-06-30ProductOther6,363,000USD0001628280-23-028419
    Q2 2022Quarterly · 2022-06-30ProductProduct Cell Processing15,356,000USD0001628280-23-028419
    Q2 2022Quarterly · 2022-06-30ProductProduct Freezer And Thaw18,670,000USD0001628280-23-028419
    Q2 2022Quarterly · 2022-06-30ProductService Freezer And Thaw0USD0001628280-23-028419
    Q2 2022Quarterly · 2022-06-30ProductStorage And Storage Services Product Revenue144,000USD0001628280-23-028419
    Q1 2022Quarterly · 2022-03-31ProductOther5,832,000USD0001437749-23-013777
    Q1 2022Quarterly · 2022-03-31ProductProduct Cell Processing14,899,000USD0001437749-23-013777
    Q1 2022Quarterly · 2022-03-31ProductProduct Freezer And Thaw15,335,000USD0001437749-23-013777
    Q1 2022Quarterly · 2022-03-31ProductService Freezer And Thaw0USD0001437749-23-013777
    Q1 2022Quarterly · 2022-03-31ProductStorage And Storage Services Product Revenue154,000USD0001437749-23-013777
    FY 2021Yearly · 2021-12-31ProductOther17,243,000USD0001628280-24-008061
    FY 2021Yearly · 2021-12-31ProductProduct Biostorage Services328,000USD0001628280-24-008061
    FY 2021Yearly · 2021-12-31ProductProduct Cell Processing44,965,000USD0001628280-24-008061
    FY 2021Yearly · 2021-12-31ProductProduct Freezer And Thaw56,620,000USD0001628280-24-008061
    FY 2021Yearly · 2021-12-31ProductService Freezer And Thaw0USD0001628280-24-008061
    Q3 2021Quarterly · 2021-09-30ProductOther4,599,000USD0001437749-22-026629
    Q3 2021Quarterly · 2021-09-30ProductProduct Cell Processing11,505,000USD0001437749-22-026629
    Q3 2021Quarterly · 2021-09-30ProductProduct Freezer And Thaw17,610,000USD0001437749-22-026629
    Q3 2021Quarterly · 2021-09-30ProductServices Cell Processing0USD0001437749-22-026629
    Q3 2021Quarterly · 2021-09-30ProductStorage And Storage Services Product Revenue86,000USD0001437749-22-026629
    Q2 2021Quarterly · 2021-06-30ProductProduct27,468,000USD0001437749-21-020183
    Q2 2021Quarterly · 2021-06-30ProductRental Revenue1,773,000USD0001437749-21-020183
    Q2 2021Quarterly · 2021-06-30ProductService Revenue1,963,000USD0001437749-21-020183
    Q1 2021Quarterly · 2021-03-31ProductOther3,071,000USD0001437749-22-011722
    Q1 2021Quarterly · 2021-03-31ProductProduct Cell Processing8,928,000USD0001437749-22-011722
    Q1 2021Quarterly · 2021-03-31ProductProduct Freezer And Thaw4,848,000USD0001437749-22-011722
    Q1 2021Quarterly · 2021-03-31ProductProduct Storage And Cold Chain Services0USD0001437749-22-011722
    FY 2020Yearly · 2020-12-31ProductOther3,547,000USD0001437749-23-008875
    FY 2020Yearly · 2020-12-31ProductProduct Cell Processing30,946,000USD0001437749-23-008875
    FY 2020Yearly · 2020-12-31ProductProduct Freezer And Thaw13,548,000USD0001437749-23-008875
    FY 2020Yearly · 2020-12-31ProductProduct Storage And Cold Chain Services46,000USD0001437749-23-008875
    FY 2020Yearly · 2020-12-31ProductService Freezer And Thaw0USD0001437749-23-008875
    Q3 2020Quarterly · 2020-09-30ProductOther475,000USD0001437749-21-026719
    Q3 2020Quarterly · 2020-09-30ProductProduct Cell Processing7,414,000USD0001437749-21-026719
    Q3 2020Quarterly · 2020-09-30ProductProduct Freezer And Thaw3,371,000USD0001437749-21-026719
    Q3 2020Quarterly · 2020-09-30ProductProduct Storage And Cold Chain Services19,000USD0001437749-21-026719
    Q3 2020Quarterly · 2020-09-30ProductService Revenue0USD0001437749-21-026719
    Q3 2020Quarterly · 2020-09-30ProductService Storage And Cold Chain Services0USD0001437749-21-026719
    Q2 2020Quarterly · 2020-06-30ProductProduct9,489,000USD0001437749-21-020183
    Q2 2020Quarterly · 2020-06-30ProductRental Revenue431,000USD0001437749-21-020183
    Q2 2020Quarterly · 2020-06-30ProductService Revenue0USD0001437749-21-020183
    Q1 2020Quarterly · 2020-03-31ProductProduct11,727,000USD0001437749-21-012506
    Q1 2020Quarterly · 2020-03-31ProductRental Revenue435,000USD0001437749-21-012506
    Q1 2020Quarterly · 2020-03-31ProductService Revenue0USD0001437749-21-012506
    FY 2019Yearly · 2019-12-31ProductAutomated Thawing Products1,184,000USD0001437749-21-007867
    FY 2019Yearly · 2019-12-31ProductBiological And Pharmaceutical Storage0USD0001437749-21-007867
    FY 2019Yearly · 2019-12-31ProductBiopreservation Media23,358,000USD0001437749-21-007867
    FY 2019Yearly · 2019-12-31ProductFreezers And Accessories2,137,000USD0001437749-21-007867
    FY 2019Yearly · 2019-12-31ProductOther527,000USD0001437749-21-007867
    FY 2019Yearly · 2019-12-31ProductProduct Revenue From Cold Chain Management165,000USD0001437749-21-007867
    FY 2019Yearly · 2019-12-31ProductService Revenue0USD0001437749-21-007867
    FY 2018Yearly · 2018-12-31ProductBio Banking1,096,000USD0001437749-19-004980
    FY 2018Yearly · 2018-12-31ProductDistribution Service6,418,000USD0001437749-19-004980
    FY 2018Yearly · 2018-12-31ProductDrug Discovery1,199,000USD0001437749-19-004980
    FY 2018Yearly · 2018-12-31ProductRegenerative Medicine11,029,000USD0001437749-19-004980
    FY 2017Yearly · 2017-12-31ProductBio Banking1,165,000USD0001437749-19-004980
    FY 2017Yearly · 2017-12-31ProductDistribution Service3,232,000USD0001437749-19-004980
    FY 2017Yearly · 2017-12-31ProductDrug Discovery1,318,000USD0001437749-19-004980
    FY 2017Yearly · 2017-12-31ProductRegenerative Medicine5,307,000USD0001437749-19-004980

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.